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Objective: Prenatal ultrasound exams have become increasingly frequent. Although no serious adverse effects are
known, the public health implications would be enormous should adverse effects on auditory development be
shown. This study looks to establish a possible correlation between hearing loss and increased prenatal ultrasound
exposure.
Design: Retrospective cohort analysis.
Setting: Tertiary academic referral center.
Methods: A retrospective review of 100 children undergoing newborn hearing screening was conducted. Extensive
data collection was performed, and this data was analyzed for a potential correlation between failure of newborn
hearing screening and increased prenatal ultrasound exposure, as well as for a potential correlation of other
variables with hearing loss.
Main outcome measures: Postnatal hearing outcomes.
Results: A higher number of both total and 3rd trimester ultrasound exams as well as a younger gestational age at
birth were all found to be significantly associated with a higher likelihood of passing the newborn hearing screen
(p<0.001 for each). No other factors were found to reach statistical significance.
Conclusions: Our results show that there is no correlation between a higher level of prenatal ultrasound exposure
and hearing loss. Indeed, infants who had more prenatal ultrasounds in the third trimester were more likely to pass
their screening hearing exams. The finding that children receiving more prenatal ultrasounds have a higher
likelihood of passing newborn hearing screens serves as an excellent reminder of the classic statistics rule that
correlation does not imply causation.
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Ultrasonography (US) now has a wide range of clinical
uses and has become virtually indispensable in many
areas of medicine. The development of prenatal US
represents one of the greater achievements in the field
of obstetrics. However, despite the widespread preva-
lence of prenatal US, it is not entirely clear whether US
waves are free of risk to the developing fetus. Because of
the increasing use of this imaging modality, the public
health implications of any potential adverse effects are
enormous. These concerns are even more important in* Correspondence: charbarger@gmail.com
1Department of Otolaryngology / Head and Neck Surgery, Georgia Regents
University, 1120 15th Street, BP 4109, Augusta, GA 30912, USA
Full list of author information is available at the end of the article
© 2013 Harbarger et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orlight of the fact that routine US screening of the fetus
has not been shown to improve perinatal morbidity
[1,2], despite an 80% detection rate of fetal anomalies at
experienced centers [3].
Only a small number of studies have investigated the
immediate and long-term effects of US on fetal develop-
ment. Links have been proposed between increased US
exposure and handedness [4-6], neurological deficits
such as speech delay [7], and low birth weight and size
[8,9]. Recent studies have also implicated that prolonged
exposure to US affects the migration of brain cells in
fetal mice [10]. To date in English literature, only one
study has looked to assess the potential effect of US on
auditory pathway development [11]. Although there was
no identified correlation between ultrasound exposed vs.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study was conducted over the years 1968–1972 and thus
predates the recent surge in average number of prenatal
ultrasound exams. Thus, this study looks to revisit this
topic with an analysis of contemporary data.
Methods
After appropriate Institutional Review Board approval, a
retrospective chart review was conducted, using CPT
codes for newborn hearing screening over the time period
01/01/2007 to 12/31/2010. Records were reviewed of
both children and mothers for fifty children found to
have normal (passed) newborn hearing screens and also
for 50 children with abnormal (failed) newborn hearing
screens.
Hearing screens conducted in the well-newborn nur-
sery were conducted as distortion-product otoacoustic
emissions (DPOAE) and those conducted in the neo-
natal intensive care unit were done as auditory brain-
stem response (ABR) tests. Data collected included the
number of prenatal US exams in each trimester, peri-
natal and pregnancy complications, gestational age at
birth, presence of perinatal hypoxia at birth, maternal
substance abuse, maternal age at birth, presence of oto-
logic abnormalities at birth, use of ototoxic medications
prenatally or postnatally, comorbidities, birth condition,
post-natal course, family history of hearing loss, APGAR
scores at 1 and 5 minutes, type and degree of documen-
ted hearing loss when available, and length of follow-up.
To allow statistical comparison, we classified obstetrical
events using the McNeil-Sjostrom Obsterics Complica-
tion Scale, which is an established systematic evaluationTable 1 Patient demographics
Dependent variable All patients (n=100)
GA birth 255.9 (95%CI +/−43.5)
US 1st trimester 0.9 (95%CI +/− 2.2)
US 2nd trimester 1.84 (95%CI +/− 2.8)
US 3rd trimester 5.01 (95%CI +/−7.1)
US total 7.77 ((95%CI +/−8.9)
McNeil Sjostrom score 2.73 (95%CI +/−)
ASA score 1.38 (95%CI +/− 1.3)
Maternal substance abuse 0.14 (95%CI +/− 0.1)
Perinatal hypoxia 0.09 (95%CI +/−0.6)
Otologic abnormalities none
Familial history of hearing loss none
Prenatal ototoxic medication 0.02 (95%CI +/− 0.3)
Postnatal ototoxic medication 0.13 (95%CI +/− 0.7)
Apgar 1 7.38 (95%CI +/− 3.7)
Apgar 5 8.28 (95%CI +/− 2.7)
maternal age at birth 27.79 (95%CI +/− 13.0)and weighting of several hundred specific somatic condi-
tions and events during pregnancy, labor-delivery, and
the prenatal period [12,13]. We used the American Soci-
ety of Anesthesiology physical status classification
scheme (“ASA grade”) to classify children’s comorbidity
status [14]. For statistical analysis, patients were categor-
ized as failing a hearing screen in at least one ear versus
passing both ears. Differences between groups were then
compared using the non-parametric Wilcoxon Rank-
Sums test for each variable assessed. We also performed
a logistic regression using forward entry of each variable
found to be significant in independent analysis or con-
sidered clinically important. Non-parametric Spearman’s
correlation was used to assess for co-variance between
gestational age and number of US performed in the third
trimester. For all tests a p<0.05 was considered signifi-
cant, and testing was performed using SPSS version 20
(IBM corporation, Armonk, NY).
Results
Demographics of both the hearing screen failures and
control group are summarized in Table 1. Thirty two
children in the study group failed the hearing screen in
1 ear, 18 failed in both ears, and the control patients
(n=50) passed hearing screens in both ears for a total
number of 100 children.
Using the non-parametric Wilcoxon Rank-Sums test,
there was found to be a significant difference in both total
number of ultrasounds (p<0.001 respectively) and ultra-
sounds in the third trimester (p<0.001) between patients
with and without failed hearing screens (see Figures 1, 2,
3). Patients who failed screening in at least 1 ear had aPass both (n=50) Fail at least one ear (n=50)
244.66 (95%CI +/− 41.0) 267.08 (95%CI +/−34.2)
1.02 (95%CI +/− 2.2) 0.82 (95%CI +/−2.1)
2.10 (95%CI +/− 3.4) 1.58 (95%CI +/−1.9)
6.66 (95%CI +/−6.1) 3.36 (95%CI +/−6.6)
9.78 (95%CI +/− 8.1) 5.76 (95%CI +/− 8.0)
2.86 (95%CI +/−1.5) 2.60 (95%CI +/− 2.1)
1.48 (95%CI +/− 1.4) 1.28 (95%CI +/− 1.6)
0.14 (95%CI +/− 0.7) 0.14 (95%CI +/− 0.7)
0.10 (95%CI +/-0.6) 0.08 (95%CI +/− 0.5)
none none
none none
none 0.04 (95%CI +/− 0.4)
0.14 (95%CI +/− 0.7) 0.12 (95%CI +/− 0.64)
6.84 (95%CI +/− 4.3) 7.92 (95%CI +/− 2.6)
7.92 (95%CI +/− 3.2) 8.64 (95%CI +/− 2.0)
27.94 (95%CI +/− 13.1) 27.64 (95%CI +/− 13)
Figure 1 Hearing status and total ultrasound exposure.
Figure 3 Ultrasound exams per trimester.
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exams, and 2 (range 0 to 15) exams in the third trimester,
compared to 9.5 (range 1–18) and 6.5 (range 0–13) US exams
respectively in the control group (Figure 1). Spearman’s correl-
ation found a significant association between gestational age
and total number of ultrasounds performed in the third tri-
mester (rho= −0.31, p=0.002, see Figure 4). To further explore
this association we divided gestational age into quartiles. As
summarized in Figure 5, patients in the highest gestational age
quartile (e.g. those born at the latest gestational ages) had
fewer ultrasounds compared to the other quartiles.
A binary logistic regression analysis in a stepwise for-
ward fashion showed that both a higher number of 3rd
trimester ultrasound exams performed (p=0.01) and a
younger gestational age at birth (p<0.001) were signifi-
cantly associated with a higher likelihood of passing the
newborn hearing screen (Table 2). No other factors were
found to reach statistical significance.Figure 2 Hearing screen and 3rd trim US exposure.Discussion
Diagnostic levels of US have been shown to induce bone
formation and have therefore been used therapeutically
for a number of years for the treatment of bone fractures
[15-17]. US has also been shown to stimulate chondro-
genesis of mesenchymal (cartilage) stem cells [18]. Reher
et al. [19] found that with diagnostic exposure, osteo-
blasts produced nitric oxide (NO), a free radical which
has been linked to both outer hair cell injury and sen-
sorineural hearing loss [20]. Likewise, other studies have
noted increased nitric oxide synthase (NOS) and NO ac-
tivity in other tissue types following US exposure
[21,22]. Indeed, there have been concerns that prenatal
US could be associated with sensorineural hearing loss,
despite a study by Stark et al. in 1984 that failed to show
an association [11]. One recent study found that chil-
dren with delayed speech were roughly 3 times more
likely to have been exposed to prenatal US, although the
authors did conclude that it was premature to presume
causation [23].Figure 4 Gestational age and 3rd trimester US exams.
Figure 5 US exams in 3rd trimester.
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increased prevalence of its use, but also its deregulation
in the 1990s [24]. Denser body tissues necessitate higher
intensity outputs in order to penetrate deeply enough to
produce images of adequate clarity and resolution [25].
With increasing rates of obesity and the consequent
need to accommodate US for use on increasing body
sizes, the FDA has loosened regulations on the max-
imum intensity allowed for clinical use.
Despite the above concerns, in the 40 years since intro-
duction into clinical practice, US has not been directly asso-
ciated with any significant health risk to the fetus orTable 2 Analysis of variables’ association with hearing
loss
Variable Significance
US exams in 1st trimester .173
US exams in 2nd trimester .365
US exams in 3rd trimester .001









Ototoxic meds prenatally .999
Ototoxic meds postnatally .993
Maternal age at birth .069
Apgar score at 1 minute .195
Apgar score at 5 minutes .748mother [26]. The American Institute of Ultrasound in
Medicine has stated that prenatal US should be performed
according to the ALARA principle (As Low As Reasonably
Achievable), and that it should be performed only with a
valid medical indication and with the lowest outputs neces-
sary. Additionally, both the American Institute of Ultra-
sound in Medicine and the Food and Drug Administration
have discouraged the use of US for "keepsake fetal imaging",
although this remains prevalent. Additionally, litigation fac-
tors may also be driving the increasing use of US. Failure to
perform an ultrasound, cardiotocograph or other medical
tests at appropriate times is commonly cited in lawsuits
against doctors, midwives, and hospitals [27].
Our results show that there is no correlation between a
higher level of US exposure prenatally and hearing loss, in
fact quite the opposite is true, particularly in the case of
third trimester US exams. The otic placode develops dur-
ing weeks 4–8 of life and inner ear development is
complete by the 26th week of gestation. Our presumption
was that the inner ear would be most susceptible to
ultrasound-induced injury during this developmental
period of the 1st and 2nd trimesters. An increased level of
ultrasound exposure during this period proved to have no
adverse effects on hearing outcomes. Our initial explan-
ation for these findings was that infants born at later ges-
tational age tend to be healthier and more neurologically
mature, thus more likely have better hearing outcomes,
and that the longer third trimester simply provided an op-
portunity for more ultrasound examinations. However,
with further analysis of the data we found that patients in
the highest gestational age quartile had fewer ultrasounds
compared to the other quartiles. Thus, we cannot fully ex-
plain the better hearing outcomes in the face of increased
US exposure, but it is plausible to assume that there is a
confounding variable that is associated with improved
hearing and more US exams being performed. Although
the data show a positive association between number of
US exams performed and passing hearing screening in
both ears, it is unlikely that US is in and of itself directly
protective or beneficial in hearing.
Additionally, we are unable to fully explain our finding
that infants passing the newborn hearing screen tended
to be younger in comparison to infants that failed. In
further analysis of these groups, the only significant dif-
ference that was seen was a disproportionately higher
number of twins included in the control group that
passed. Our initial thought was that twins are generally
born earlier in gestational age, but often are healthier in
comparison to non-twin hearing screen failures, and
thus may have been more likely in comparison to have
better hearing outcomes. This did not seem to be sup-
ported by further analysis, as twin vs. non-twin compari-
son found relatively equal distributions in the ASA and
McNeil Sjostrom scores across both groups.
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ture. Another is that the majority of hearing screens
were done as DPOAE’s, which although a reasonable
measure of cochlear function, may be negative in the
face of a hearing loss of up to 30–40 dB. Thus, our
results may have missed a sub-threshold hearing loss
that is actually occurring. Additionally, our study had a
relatively small n and may not have the power to detect
a difference if present.
In summary, we found no correlation between a higher
level of prenatal ultrasound exposure and hearing loss - in
fact quite the opposite is true, particularly in the case of
third trimester US exams. Our finding that infants receiv-
ing more 3rd trimester ultrasounds have better hearing
outcomes serves as an excellent reminder of the classic
statistics rule that correlation does not imply causation.
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